Sierra Oncology Inc (SRRA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Sierra Oncology Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
SRRA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The upside potential (average analyst target price relative to current price) of SRRA is greater than 84.32% of all US stocks.
- SRRA has a lower variance in analysts' estimates than 30.93% of stocks in the small market cap category.
- SRRA has a higher average analyst price target than 66.96% of stocks in the small market cap category.
- SRRA has a greater number of analysts covering the stock than 35.45% of Pharmaceutical Products stocks.
- Sierra Oncology Inc's percent of analysts bearish on the stock is lower than nearly 100% of all US stocks.
- Sierra Oncology Inc's percentage of analysts bullish on the stock is higher than nearly none of all US stocks.
- SRRA has a lower change in bullishness amongst analysts than nearly 100% of all US stocks.
Is SRRA a Buy, Hold or Sell? See the POWR Ratings now!